(R)-N-Boc-2-hydroxymethylmorpholine

(R)-N-Boc-2-hydroxymethylmorpholine

(R)-N-Boc-2-Hydroxymethylmorpholine (CAS 135065-71-3) is the N-Boc-protected form of enantiopure (R)-morpholine-2-methanol: a six-membered morpholine ring bearing a hydroxymethyl group at the 2-position, with the ring nitrogen masked as a tert-butoxycarbonyl (Boc) carbamate.
Send Inquiry

English synonyms :(R)-N-Boc-2-hydroxymethylmorpholine

English synonyms:(R)-N-Boc-2-hydroxymethylmorpholine;(R)-4-Boc-2-hydroxymethylmorpholine;(R)-2-Hydroxymethyl-4-Boc-morpholine;tert-Butyl (2R)-2-(hydroxymethyl)morpholine-4-carboxylate;(R)-tert-Butyl 2-(hydroxymethyl)morpholine-4-carboxylate;(R)-4-tert-Butoxycarbonyl-2-(hydroxymethyl)morpholine;(R)-N-Boc-2-morpholinemethanol;MFCD09260605

CAS number :135065-71-3

Molecular formula : C10H19NO4

Molecular weight :217.26

Properties: White to off-white crystalline solid, mp 59-61°C

Content: ≥99%(HPLC) Professional scientific accurate detection

Function: Used in foreign trade export, scientific research and chemical reagents and other fields; it is employed mainly as an enantiopure chiral building block (N-Boc-protected (R)-morpholine-2-methanol) for the synthesis of 2-substituted morpholine derivatives in pharmaceutical research and organic synthesis.

Packing: 1G 100G 500G 1KG

Storage: Dry, sealed under inert gas (N2 or Ar), stored at 2-8℃, shelf life of 2 years

 

Structural formula:

product-560-400

(R)-N-Boc-2-hydroxymethylmorpholine use and synthesis method

 

Intro

(R)-N-Boc-2-Hydroxymethylmorpholine (CAS 135065-71-3) is the N-Boc-protected form of enantiopure (R)-morpholine-2-methanol: a six-membered morpholine ring bearing a hydroxymethyl group at the 2-position, with the ring nitrogen masked as a tert-butoxycarbonyl (Boc) carbamate. The free primary alcohol provides a handle for further elaboration (sulfonate activation, oxidation, etherification), while the Boc group tames the secondary amine and can be removed under mild acid to release the free morpholine late in a synthesis. Key identifiers: molecular formula C10H19NO4, molecular weight 217.26, MDL MFCD09260605, EC 815-640-3, PubChem CID 1512576, InChIKey FJYBLMJHXRWDAQ-MRVPVSSYSA-N, IUPAC name tert-butyl (2R)-2-(hydroxymethyl)morpholine-4-carboxylate. Commercial material (e.g. Alfa Aesar / Thermo Scientific, catalogue H60062) is specified at 99% purity (assay by HPLC).

 

Peculiarity

The compound combines three practical features: (i) an (R)-configured stereocentre at C2, fixed next to the ring oxygen, which transmits chirality into downstream 2-substituted morpholines; (ii) a chemically orthogonal pair of functions - a primary alcohol that is readily converted into tosylates/mesylates or oxidised (e.g. TEMPO) to N-Boc-morpholine-2-carboxylic acid, and an acid-labile Boc carbamate removable with HCl/dioxane or TFA; (iii) good crystallinity and stability (mp 59-61°C). Reported/calculated data: boiling point ca. 321°C, density 1.118 g/cm3, flash point ca. 148°C, pKa 14.36 ± 0.10 (predicted); hazard classification GHS07 (Warning), H315 (skin irritation), H319 (serious eye irritation), H335 (respiratory irritation); HS code 2934999090. The boiling point, density, flash point and pKa figures are calculated/predicted values.

 

Uses

This compound is a synthetic intermediate, not a drug substance, and has no pharmacological activity of its own. N-Boc-2-hydroxymethylmorpholine is a documented chiral intermediate for 2-substituted morpholine chemotypes used in CNS and receptor-ligand programmes: the primary literature and the patents cited therein describe its use in the preparation of histamine H3 receptor antagonists and other morpholine-containing active compounds, and (R)-2-hydroxymethylmorpholine derivatives such as N-(3,4-dichlorobenzyl)-(R)-2-hydroxymethylmorpholine and (R)-2-benzylmorpholine are described as pharmacologically active morpholines. More recently, chiral 2-substituted morpholine residues appear in the RAS(ON) G12C-selective tri-complex inhibitor elironrasib (RMC-6291, Revolution Medicines, CAS 2641998-63-0, C55H78FN9O8, MW 1012.26), whose published chemical name contains a defined (2R)-2-morpholinyl unit;

 

Synthesis and representative transformations

Enantioselective access is well documented. Henegar (Pfizer) reported an operationally simple, chromatography-free synthesis of N-Boc-2-hydroxymethylmorpholine and N-Boc-morpholine-2-carboxylic acid from epichlorohydrin (J. Org. Chem. 2008, 73(9), 3662-3665; the (S)-series is described and the (R)-series is accessible by the same chemistry from (R)-epichlorohydrin). Sawant and Waghmode achieved a concise, high-yielding enantioselective synthesis of (R)-N-Boc-2-hydroxymethylmorpholine using proline-catalysed asymmetric alpha-aminooxylation of an aldehyde and palladium-catalysed intramolecular reductive amination of an azido aldehyde as key steps (Tetrahedron 2010, 66(11), 2010-2014). A practical late-stage route converts (2R)-4-tosyl-2-hydroxymethylmorpholine to the free amine by reductive detosylation (sodium naphthalenide, THF) followed by in-situ protection with di-tert-butyl dicarbonate (Boc2O/NaHCO3, aq. dioxane), reported in 82% yield. Common upstream alternatives are direct Boc protection of ((R)-morpholin-2-yl)methanol, reduction of (R)-4-Boc-morpholine-2-carboxylic acid, or hydrogenolytic debenzylation of (R)-tert-butyl 2-((benzyloxy)methyl)morpholine-4-carboxylate.

Starting materials: ((R)-Morpholin-2-yl)methanol (Boc protection); (R)-4-(tert-butoxycarbonyl)morpholine-2-carboxylic acid (reduction); (R)-tert-butyl 2-((benzyloxy)methyl)morpholine-4-carboxylate (hydrogenolysis); or (2R)-N-tosyl-2-hydroxymethylmorpholine (reductive detosylation).

Reagents and conditions: Boc2O with NaHCO3 or NaOH in aq. dioxane/THF for N-protection; H2, Pd/C for benzyl ether removal; sodium naphthalenide in THF at 0°C for detosylation; typical work-up by extraction and crystallisation or silica filtration.

Representative transformations: sulfonylation of the alcohol (TsCl or MsCl) to give activated sulfonates; TEMPO-mediated oxidation to (R)-N-Boc-morpholine-2-carboxylic acid; nucleophilic substitution of the sulfonate with O-/N-nucleophiles to form 2-aryloxymethylmorpholines; Boc removal with HCl/dioxane or TFA/CH2Cl2 to give the free amine salt.

Yields and specifications: 82% reported for the detosylation/Boc-protection sequence; enantioselective routes give high enantiomeric excess of the (R)-isomer; commercial material is specified at 99% purity (Alfa Aesar assay by HPLC), white to off-white solid.

Hot Tags: (r)-n-boc-2-hydroxymethylmorpholine, China (r)-n-boc-2-hydroxymethylmorpholine suppliers, 1118767-16-0, 119302-20-4, 119302-24-8, 179162-55-1, drug product intermediate, Posaconazole intermediate antifungal drug